Overall net revenue from sales in Q1 was $8.3 million, the company said. ・The company said that it now has funds to sustain itself till the second quarter of 2027. ・Total net revenue from sales of ...

CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced that it intends to ...

Fintel reports that on May 4, 2026, TD Cowen initiated coverage of Tonix Pharmaceuticals Holding (NasdaqGS:TNXP) with a Buy ...

View Tonix Pharmaceuticals Holding Corp. TNXP stock quote prices, financial information, real-time forecasts, and company news from CNN.

Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA ...

CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated commercial-stage biotechnology company today ...

CHATHAM, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (“Tonix” or the “Company”), a fully-integrated commercial stage biotechnology company, today announced it ...

BERKELEY HEIGHTS, N.J., March 03, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully integrated, commercial biotechnology company, today ...

TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significantly attenuated tumor progression in aged ...

On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s (NASDAQ:TNXP) Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults.